A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors.
D000284:Administration, Oral; D000818:Animals; D000927:Anticonvulsants / Q000138:chemical synthesis*; D007202:Indicators and Reagents; D008297:Male; D051379:Mice; D010433:Pentylenetetrazole; D011720:Pyrazoles / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D011804:Quinolines / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology; D011963:Receptors, GABA-A / Q000187:drug effects / Q000378:metabolism*; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology; D013876:Thiophenes / Q000008:administration & dosage / Q000138:chemical synthesis* / Q000494:pharmacology
D000927:Anticonvulsants; D007202:Indicators and Reagents; D011720:Pyrazoles; D011804:Quinolines; D011963:Receptors, GABA-A; D013876:Thiophenes; D010433:Pentylenetetrazole